Circulating maternal perfluoroalkyl substances during pregnancy in the C8 health study

Environmental Science and Technology

Volumn 47, Issue 3, 2013, Pages 1606-1613

  Javins, Beth ^a   Hobbs, Gerald ^a   Ducatman, Alan M ^a   Pilkerton, Courtney ^a   Tacker, Danyel ^a   Knox, Sarah S ^a  

^a WEST VIRGINIA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL STUDIES; CRITICAL PERIODS; FETAL DEVELOPMENT; HEALTH-STUDY; HUMAN STUDY; PERFLUOROCARBONS; PERFLUOROOCTANOIC ACID; PERIPHERAL BLOOD; PREGNANT WOMAN; SYSTEMATIC STUDY;

ANIMALS; CONSUMER PRODUCTS;

OBSTETRICS;

DRINKING WATER; HEMOGLOBIN; PERFLUOROOCTANESULFONIC ACID; PERFLUOROOCTANOIC ACID;

CARBOXYLIC ACID; ENDOCRINE DISRUPTOR; HEALTH RISK; INDUSTRIAL WASTE; POLLUTION EXPOSURE; PREGNANCY;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; EDUCATIONAL STATUS; FEMALE; FETUS DEVELOPMENT; FIRST TRIMESTER PREGNANCY; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN TISSUE; INCOME; INDUSTRIAL WASTE; MAJOR CLINICAL STUDY; MATERNAL SMOKING; PARITY; PLASMA VOLUME; PREGNANT WOMAN; PRENATAL EXPOSURE; SECOND TRIMESTER PREGNANCY; SOCIAL STATUS; THIRD TRIMESTER PREGNANCY; UNITED STATES; WATER CONTAMINATION;

ADOLESCENT; ADULT; ALKANESULFONIC ACIDS; CAPRYLATES; FEMALE; FLUOROCARBONS; HEALTH; HUMANS; MOTHERS; OHIO; PREGNANCY; PREGNANCY TRIMESTERS; WEST VIRGINIA; YOUNG ADULT;

EID: 84873473559     PISSN: 0013936X     EISSN: 15205851     Source Type: Journal    
DOI: 10.1021/es3028082     Document Type: Article

References (58)

1. Poulsen, P. B.; Jensen, A. A.; Wallström, E.; Aps, E. More environmentally friendly alternatives to PFOS-compounds and PFOA. Environmental Project No. 1013, Danish Ministry of the Environment, 2005.
2. Houde, M.; Martin, J. W.; Letcher, R. J.; Solomon, K. R.; Muir, D. C. G. Biological monitoring of polyfluoroalkyl substances: a review Environ. Sci. Technol. 2006, 40 (11) 3463-3473
3. Martin, J. W.; Smithwick, M. M.; Braune, B. M.; Hoekstra, P. F.; Muir, D. C. G.; Mabury, S. A. Identification of long-chain perfluorinated acids in biota from the Canadian Arctic Environ. Sci. Technol. 2003, 38 (2) 373-380
4. Calafat, A. M.; Wong, L.; Kuklenyik, Z.; Reidy, J. A.; Needham, L. L. Polyfluoroalkyl chemicals in the U.S. population: data from the National Health and Nutrition Examination Survey (NHANES) 2003-2004 and comparisons with NHANES 1999-2000 Environ. Health Perspect. 2007, 115 (11) 1596-1602
5. Luebker, D. J.; York, R. G.; Hansen, K. J.; Moore, J. A.; Butenhoff, J. L. Neonatal mortality from in utero exposure to perfluorooctanesulfonate (PFOS) in Sprague-Dawley rats: dose-response, and biochemical and pharamacokinetic parameters Toxicology 2005, 215 (1-2) 149-169
6. Grasty, R. C.; Grey, B. E.; Lau, C. S.; Rogers, J. M. Prenatal window of susceptibility to perfluorooctanesulfonate induced neonatal mortality in the Sprague Dawley rat Birth Defects Res., Part B 2003, 68 (6) 465-471
7. Lau, C.; Thibodeaux, J. R.; Hanson, R. G.; Narotsky, M. G.; Rogers, J. M.; Lindstrom, A. B.; Strynar, M. J. Effects of perfluorooctanoic acid exposure during pregnancy in the mouse Toxicol. Sci. 2006, 90 (2) 510-518
8. Thibodeaux, J. R.; Hanson, R. G.; Rogers, J. M.; Grey, B. E.; Barbee, B. D.; Richards, J. H.; Butenhoff, J. L.; Stevenson, L. A.; Lau, C. Exposure to perfluorooctanesulfonate during pregnancy in rat and mouse. I: maternal and prenatal evaluations Toxicol. Sci. 2003, 74 (2) 369-381
9. Yahia, D.; Tsukuba, C.; Yoshida, M.; Sato, I.; Tsuda, S. Neonatal death of mice treated with perfluorooctanesulfonate J. Toxicol. Sci. 2008, 33 (2) 219-226
10. Case, M. T.; York, R. G.; Christian, M. S. Rat and rabbit oral developmental toxicology studies with two perfluorinated compounds Int. J. Toxicol. 2001, 20 (2) 101
11. Grasty, R. C.; Bjork, J.; Wallace, K.; Lau, C.; Rogers, J. Effects of prenatal perfluorooctane sulfonate (PFOS) exposure on lung maturation in the perinatal rat Birth Defects Res., Part B 2005, 74 (5) 405-416
12. Arbuckle, T. E.; Kubwabo, C.; Walker, M.; Davis, K.; Lalonde, K.; Kosarac, I.; Wen, S. W.; Arnold, D. L. Umbilical cord blood levels of perfluoroalkyl acids and polybrominated flame retardants. Int. J. Hyg. Environ. Health 2012, (available online April 9, 2012) not supplied.
13. Inoue, K.; Okada, F.; Ito, R.; Kato, S.; Sasaki, S.; Nakajima, S.; Uno, A.; Saijo, Y.; Sata, F.; Yoshimura, Y. Perfluorooctane sulfonate (PFOS) and related perfluorinated compounds in human maternal and cord blood samples: assessment of PFOS exposure in a susceptible population during pregnancy Environ. Health Perspect. 2004, 112 (11) 1204-1207
14. Fromme, H.; Mosch, C.; Morovitz, M.; Alba-Alejandre, I.; Boehmer, S.; Kiranoglu, M.; Faber, F.; Hannibal, I.; Genzel-Boroviczény, O.; Koletzko, B.; Völkel, W. Pre- and postnatal exposure to perfluorinated compounds (PFASs) Environ. Sci. Technol. 2010, 44 (18) 7123-7129
15. Apelberg, B. J.; Witter, F. R.; Herbstman, J. B.; Calafat, A. M.; Halden, R. U.; Needham, L. L.; Goldman, L. R. Cord serum concentrations of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) in relation to weight and size at birth Environ. Health Perspect. 2007, 115 (11) 1670
16. Fei, C.; McLaughlin, J. K.; Tarone, R. E.; Olsen, J. Perfluorinated chemicals and fetal growth: a study within the Danish National Birth Cohort Environ. Health Perspect. 2007, 115 (11) 1677-1682
17. Monroy, R.; Morrison, K.; Teo, K.; Atkinson, S.; Kubwabo, C.; Stewart, B.; Foster, W. G. Serum levels of perfluoroalkyl compounds in human maternal and umbilical cord blood samples Environ. Res. 2008, 108 (1) 56-62
18. Gützkow, K. B.; Haug, L. S.; Thomsen, C.; Sabaredzovic, A.; Becher, G.; Brunborg, G. Placental transfer of perfluorinated compounds is selective-a Norwegian mother and child sub- cohort study Int. J. Hyg. Environ. Health 2012, 215 (2) 216-219
19. Woodruff, T. J.; Zota, A. R.; Schwartz, J. M. Environmental chemicals in pregnant women in the United States: NHANES 2003-2004 Environ. Health Perspect. 2011, 119 (6) 878-885
20. Frisbee, S. J.; Brooks, A. P.; Maher, A.; Flensborg, P.; Arnold, S.; Fletcher, T.; Steenland, K.; Shankar, A.; Knox, S. S.; Pollard, C.; Halverson, J. A.; Vieira, V. M.; Jin, C. F.; Leyden, K. M.; Ducatman, A. M. The C8 Health Project: design, methods, and participants Environ. Health Perspect. 2009, 117 (12) 1873-1882
21. Burd, L.; Roberts, D.; Olson, M.; Odendaal, H. Ethanol and the placenta: a review J. Matern.-Fetal Neonat. Med. 2007, 20 (5) 361-375
22. Habek, D.; Habek, J. Č.; Ivanišević, M.; Djelmiš, J. Fetal tobacco syndrome and perinatal outcome Fetal Diagn. Ther. 2002, 17 (6) 367-371
23. Faupel-Badger, J. M.; Hsieh, C. C.; Troisi, R.; Lagiou, P.; Potischman, N. Plasma volume expansion in pregnancy: implications for biomarkers in population studies Cancer Epidemiol. Biomarkers Prev. 2007, 16 (9) 1720-1723
24. Farjanel, J.; Denis, C.; Chatard, J. C.; Geyssant, A. An accurate method of plasma volume measurement by direct analysis of Evans blue spectra in plasma without dye extraction: origins of albu min-space variations during maximal exercise Eur. J. Appl. Physiol. Occup. Physiol. 1996, 75 (1) 75-82
25. Knox, S. S.; Jackson, T.; Javins, B.; Frisbee, S. J.; Shankar, A.; Ducatman, A. M. Implications of early menopause in women exposed to perfluorocarbons J. Clin. Endocrinol. Metab. 2011, 96 (6) 1747-1753
26. Jensen, M. S.; Nørgaard-Pedersen, B.; Toft, G.; Hougaard, D. M.; Bonde, J. P.; Cohen, A.; Thulstrup, A. M.; Ivell, R.; Anand-Ivell, R.; Lindh, C. H.; Jönsson, B. A. G. Phthalates and perfluorooctanesulfonic acid in human amniotic fluid: temporal trends and timing of amniocentesis in pregnancy Environ. Health Perspect. 2012, 120 (6) 897-903
27. Yamada, S.; Samtani, R. R.; Lee, E. S.; Lockett, E.; Uwabe, C.; Shiota, K.; Anderson, S. A.; Lo, C. W. Developmental atlas of the early first trimester human embryo Dev. Dyn. 2010, 239 (6) 1585-1595
28. Waterland, R. A.; Michels, K. B. Epigenetic epidemiology of the developmental origins hypothesis Annu. Rev. Nutr. 2007, 27, 363-388
29. Sinclair, K. D.; Allegrucci, C.; Singh, R.; Gardner, D. S.; Sebastian, S.; Bispham, J.; Thurston, A.; Huntley, J. F.; Rees, W. D.; Maloney, C. A. DNA methylation, insulin resistance, and blood pressure in offspring determined by maternal periconceptional B vitamin and methionine status Proc. Natl. Acad. Sci. U.S.A. 2007, 104 (49) 19351-19356
30. Tian, M.; Peng, S.; Martin, F. L.; Zhang, J.; Liu, L.; Wang, Z.; Dong, S.; Shen, H. Perfluorooctanoic acid induces gene promoter hypermethylation of glutathione-S-transferase Pi in human liver L02 cells Toxicology 2012, 296 (1-3) 48-55
31. Harries, L. W.; Stubbins, M. J.; Forman, D.; Howard, G.; Wolf, C. R. Identification of genetic polymorphisms at the glutathione-S-transferase Pi locus and association with susceptibility to bladder, testicular and prostate cancer Carcinogenesis 1997, 18 (4) 641-644
32. Guerrero-Preston, R.; Goldman, L. R.; Brebi-Mieville, P.; Ili-Gangas, C.; LeBron, C.; Witter, F. R.; Apelberg, B. J.; Hernández-Roystacher, M.; Jaffe, A.; Halden, R. U. Global DNA hypomethylation is associated with in utero exposure to cotinine and perfluorinated alkyl compounds Epigenetics 2010, 5 (6) 539-546
33. Anway, M. D.; Leathers, C.; Skinner, M. K. Endocrine disruptor vinclozolin induced epigenetic transgenerational adult-onset disease Endocrinology 2006, 147 (12) 5515-5523
34. Casals-Casas, C.; Desvergne, B. Endocrine disruptors: from endocrine to metabolic disruption Annu. Rev. Physiol. 2011, 73, 135-162
35. White, S. S.; Fenton, S. E.; Hines, E. P. Endocrine disrupting properties of perfluorooctanoic acid J. Steroid Biochem. Mol. Biol. 2011, 127 (1-2) 16-26
36. Fernandez, M. F.; Olmos, B.; Granada, A.; López-Espinosa, M. J.; Molina-Molina, J. M.; Fernandez, J. M.; Cruz, M.; Olea-Serrano, F.; Olea, N. Human exposure to endocrine-disrupting chemicals and prenatal risk factors for cryptorchidism and hypospadias: a nested case-control study Environ. Health Perspect. 2007, 115 (S-1) 8-14
37. Strohsnitter, W. C.; Noller, K. L.; Hoover, R. N.; Robboy, S. J.; Palmer, J. R.; Titus- Ernstoff, L.; Kaufman, R. H.; Adam, E.; Herbst, A. L.; Hatch, E. E. Cancer risk in men exposed in utero to diethylstilbestrol J. Natl. Cancer Inst. 2001, 93 (7) 545-551
38. Swan, S. H. Intrauterine exposure to diethylstilbestrol: Long-term effects in humans APMIS 2001, 109 (S103) S210-S222
39. Palmer, J. R.; Wise, L. A.; Hatch, E. E.; Troisi, R.; Titus-Ernstoff, L.; Strohsnitter, W.; Kaufman, R.; Herbst, A. L.; Noller, K. L.; Hyer, M.; Hoover, R. N. Prenatal diethylstilbestrol exposure and risk of breast cancer Cancer Epidemiol. Biomarkers Prev. 2006, 15 (8) 1509-1514
40. Jacobson, J. L.; Jacobson, S. W. Intellectual impairment in children exposed to polychlorinated biphenyls in utero New Engl. J. Med. 1996, 335 (11) 783-789
41. Knox, S. S.; Jackson, T.; Frisbee, S. J.; Javins, B.; Ducatman, A. M. Perfluorocarbon exposure, gender and thyroid function in the C8 Health Project J. Toxicol. Sci. 2011, 36 (4) 403-410
42. Zoeller, R. T.; Crofton, K. M. Thyroid hormone action in fetal brain development and potential for disruption by environmental chemicals Neurotoxicology 2000, 21 (6) 935-946
43. Porterfield, S. P. Thyroidal dysfunction and environmental chemicals-potential impact on brain development Environ. Health Perspect. 2000, 108 (Suppl. 3) 433-438
44. Escobar, G. M.; Obregon, M. J.; Del Rey, F. E. Role of thyroid hormone during early brain development Eur. J. Endocrinol. 2004, 151 (Suppl 3) U25-U37
45. Escobar, G. M.; Obregón, M. J.; Rey, F. E. Maternal thyroid hormones early in pregnancy and fetal brain development Best Pract. Res. Clin. Endocrinol. Metab. 2004, 18 (2) 225-248
46. Henrichs, J.; Bongers-Schokking, J. J.; Schenk, J. J.; Ghassabian, A.; Schmidt, H. G.; Visser, T. J.; Hooijkaas, H.; de Muinck Keizer-Schrama, S. M. P. F.; Hofman, A.; Jaddoe, V. V. W. Maternal thyroid function during early pregnancy and cognitive functioning in early childhood: the generation R study J. Clin. Endocrinol. Metab. 2010, 95 (9) 4227-4234
47. Pop, V. J.; Kuijpens, J. L.; van Baar, A. L.; Verkerk, G.; van Son, M. M.; de Vijlder, J. J.; Vulsma, T.; Wiersinga, W. M.; Drexhage, H. A.; Vader, H. L. Low maternal free thyroxine concentrations during early pregnancy are associated with impaired psychomotor development in infancy Clin. Endocrinol. 2001, 50 (2) 149-155
48. Smit, B.; Kok, J.; Vulsma, T.; Briet, J.; Boer, K.; Wiersinga, W. Neurologic development of the newborn and young child in relation to maternal thyroid function Acta Paediatr. (Oxford, U. K.) 2000, 89 (3) 291-295
49. Abalovich, M.; Amino, N.; Barbour, L. A.; Cobin, R. H.; De Groot, L. J.; Glinoer, D.; Mandel, S. J.; Stagnaro-Green, A. Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society Clinical Practice Guideline J. Clin. Endocrinol. Metab. 2007, 92 (8 Suppl.) s1-s47
50. Ahmed, O.; Abd El-Tawab, S.; Ahmed, R. Effects of experimentally induced maternal hypothyroidism and hyperthyroidism on the development of rat offspring: I. The development of the thyroid hormones-neurotransmitters and adenosinergic system interactions Int. J. Dev. Neurosci. 2010, 28 (6) 437-454
51. Frisbee, S. J.; Shankar, A.; Knox, S. S.; Steenland, K.; Savitz, D. A.; Fletcher, T.; Ducatman, A. M. Perfluorooctanoic acid, perfluorooctanesulfonate, and serum lipids in children and adolescents: Results from the C8 Health Project Arch. Pediatr. Adolesc. Med. 2010, 164 (9) 860-869
52. Steenland, K.; Tinker, S.; Frisbeer, S.; Ducatman, A.; Vaccarino, V. Association of perfluorooctanoic acid and perfluorooctanesulfonate with serum lipids among adults living near a chemical plant Am. J. Epidemiol. 2009, 170 (10) 1268-1278
53. Napoli, C.; D'armiento, F.; Mancini, F.; Postiglione, A.; Witztum, J.; Palumbo, G.; Palinski, W. Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia. Intimal accumulation of low density lipoprotein and its oxidation precede monocyte recruitment into early atherosclerotic lesions J. Clin. Invest. 1997, 100 (11) 2680-2690
54. Palinski, W.; Napoli, C. The fetal origins of atherosclerosis: maternal hypercholesterolemia, and cholesterol-lowering or antioxidant treatment during pregnancy influence in utero programming and postnatal susceptibility to atherogenesis FASEB J. 2002, 16 (11) 1348-1360
55. Okada, E.; Sasaki, S.; Saijo, Y.; Washino, N.; Miyashita, C.; Kobayashi, S.; Konishi, K.; Ito, Y. M.; Ito, R.; Nakata, A.; Iwasaki, Y.; Saito, K.; Nakazawa, H.; Kishi, R. Prenatal exposure to perfluorinated chemicals and relationship with allergies and infectious diseases in infants Environ. Res. 2012, 112, 118-125
56. Grandjean, P.; Andersen, E. W.; Budtz-Jørgensen, E.; Nielsen, F.; Mølbak, K.; Weihe, P.; Heilmann, C. Serum vaccine antibody concentrations in children exposed to perfluorinated compounds JAMA, J. Am. Med. Assoc. 2012, 307 (4) 391-397
57. Halldorsson, T. I.; Rytter, D.; Haug, L. S.; Bech, B. H.; Danielsen, I.; Becher, G.; Henriksen, T. B.; Olsen, S. F. Prenatal exposure to perfluorooctanoate and risk of overweight at 20 years of age: a prospective cohort study Environ. Health Perspect. 2012, 120 (5) 668-673
58. Liu, J.; Li, J.; Liu, Y.; Chan, H. M.; Zhao, Y.; Cai, Z.; Wu, Y. Comparison of gestation and lactation exposure of perfluorinated compounds for newborns Environ. Int. 2012, 37, 1206-1212